Diffusion-weighted imaging in the assessment of neurological damage in patients with methylmalonic aciduria

A P Burlina1, R Manara, M Calderone

  • 1Department of Neurological and Psychiatric Sciences, Azienda Ospedale, University of Padova, Italy.

Insights

Diffusion-weighted MRI (DW-MRI) helps assess brain damage in methylmalonic aciduria. This technique differentiates acute stroke from chronic encephalopathy in affected patients, aiding neurological assessment.

Area of Science:

  • Neurology
  • Radiology
  • Metabolic Disorders

Background:

  • Methylmalonic aciduria is a rare metabolic disorder.
  • Neurological involvement can occur without overt metabolic decompensation.
  • Early assessment of brain damage is crucial for patient management.

Purpose of the Study:

  • To evaluate the utility of Diffusion-weighted magnetic resonance imaging (DW-MRI) in assessing brain damage in patients with methylmalonic aciduria.
  • To differentiate between acute and chronic neurological damage in these patients.

Main Methods:

  • Brain DW-MRI was performed on two patients with methylmalonic aciduria presenting with neurological symptoms.
  • Clinical presentation and imaging findings were correlated to assess the extent and type of brain damage.

Main Results:

  • Patient 1, with acute metabolic stroke, showed very recent brain damage on DW-MRI.
  • Patient 2, with subacute encephalopathy, had no brain lesions on DW-MRI, suggesting chronic damage.

Conclusions:

  • Brain DW-MRI is a valuable complementary tool for assessing neurological damage in methylmalonic aciduria.
  • DW-MRI can distinguish between acute and chronic brain injury in this patient population.
  • This imaging modality aids in the comprehensive evaluation of neurological syndromes associated with methylmalonic aciduria.

Related Concept Videos